Pharmacology: Difference between revisions
No edit summary |
(added cover) |
||
| Line 1: | Line 1: | ||
= = | = [[Image:PharmacologyCover1.jpg|right|318x450px]] = | ||
__TOC__ | |||
=== Introduction === | === Introduction === | ||
| Line 7: | Line 9: | ||
Dave Boothroyd | Dave Boothroyd | ||
<br> | <br> | ||
== Pure pharmacology == | == Pure pharmacology == | ||
| Line 13: | Line 15: | ||
[http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2010.01019.x/pdf Reflections on drug research]<br>James Black | [http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2010.01019.x/pdf Reflections on drug research]<br>James Black | ||
[http://onlinelibrary.wiley.com/doi/10.1038/sj.bjp.0706457/pdf The receptor concept: pharmacology’s big idea]<br>H.P. Rang<br> | [http://onlinelibrary.wiley.com/doi/10.1038/sj.bjp.0706457/pdf The receptor concept: pharmacology’s big idea]<br>H.P. Rang<br> | ||
[http://onlinelibrary.wiley.com/doi/10.1038/sj.bjp.0706454/pdf The future of pharmacology]<br>Patrick Vallance, Trevor G Smart | [http://onlinelibrary.wiley.com/doi/10.1038/sj.bjp.0706454/pdf The future of pharmacology]<br>Patrick Vallance, Trevor G Smart | ||
| Line 23: | Line 25: | ||
== Socio-pharmacology == | == Socio-pharmacology == | ||
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783660/?tool=pmcentrez Epidemiology Meets Cultural Studies: Studying and Understanding Youth Cultures, Clubs and Drugs]<br>Geoffrey Hunt, Molly Moloney, and Kristin Evans<br> | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783660/?tool=pmcentrez Epidemiology Meets Cultural Studies: Studying and Understanding Youth Cultures, Clubs and Drugs]<br>Geoffrey Hunt, Molly Moloney, and Kristin Evans<br> | ||
[http://www.substanceabusepolicy.com/content/1/1/15 Misuse of "study drugs:" prevalence, consequences, and implications for policy]<br>Steve Sussman, Mary A Pentz, Donna Spruijt-Metz and Toby Miller | [http://www.substanceabusepolicy.com/content/1/1/15 Misuse of "study drugs:" prevalence, consequences, and implications for policy]<br>Steve Sussman, Mary A Pentz, Donna Spruijt-Metz and Toby Miller | ||
[http://www.substanceabusepolicy.com/content/3/1/22 Coming to terms with the nonmedical use of prescription medications]<br>Carol J Boyd and Sean E McCabe <br> | [http://www.substanceabusepolicy.com/content/3/1/22 Coming to terms with the nonmedical use of prescription medications]<br>Carol J Boyd and Sean E McCabe <br> | ||
<br>A Better Approach to Drugs and Alcohol | <br>A Better Approach to Drugs and Alcohol | ||
| Line 33: | Line 35: | ||
Stanton Peele <youtube>9-wSS79rZPs</youtube>&nbsp | Stanton Peele <youtube>9-wSS79rZPs</youtube>&nbsp | ||
<br> | <br> | ||
== Psycho-pharmacology == | == Psycho-pharmacology == | ||
| Line 47: | Line 49: | ||
== <br>Neuro-pharmacology == | == <br>Neuro-pharmacology == | ||
[http://onlinelibrary.wiley.com/doi/10.1111/j.1742-7843.2007.00159.x/full The Dark Side of Ecstasy: Neuropsychiatric Symptoms After Exposure to 3,4-Methylenedioxymetamphetamine]<br>Sunniva Nyberg Karlsen, Olav Spigset, LARS Slørdal<br> | [http://onlinelibrary.wiley.com/doi/10.1111/j.1742-7843.2007.00159.x/full The Dark Side of Ecstasy: Neuropsychiatric Symptoms After Exposure to 3,4-Methylenedioxymetamphetamine]<br>Sunniva Nyberg Karlsen, Olav Spigset, LARS Slørdal<br> | ||
[http://onlinelibrary.wiley.com/doi/10.1111/j.1360-0443.2010.03252.x/full Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs]<br>John H. Halpern, Andrea R. Sherwood, James I. Hudson, Staci Gruber, David Kozin, Harrison G. Pope Jr | [http://onlinelibrary.wiley.com/doi/10.1111/j.1360-0443.2010.03252.x/full Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs]<br>John H. Halpern, Andrea R. Sherwood, James I. Hudson, Staci Gruber, David Kozin, Harrison G. Pope Jr | ||
<br> | <br> | ||
[http://www.peh-med.com/content/pdf/1747-5341-3-14.pdf Effectiveness of antidepressants: an evidence myth constructed<br>from a thousand randomized trials]?<br>John PA Ioannidis | [http://www.peh-med.com/content/pdf/1747-5341-3-14.pdf Effectiveness of antidepressants: an evidence myth constructed<br>from a thousand randomized trials]?<br>John PA Ioannidis | ||
| Line 61: | Line 63: | ||
Barry Everitt | Barry Everitt | ||
[http://www.frontiersin.org/integrative_neuroscience/10.3389/fnint.2011.00031/full Optimized Networks for Time Perception]<br>Martin Wiener, Matthew S. Matell and H B. Coslett<br><br><br> | [http://www.frontiersin.org/integrative_neuroscience/10.3389/fnint.2011.00031/full Optimized Networks for Time Perception]<br>Martin Wiener, Matthew S. Matell and H B. Coslett<br><br><br> | ||
== Ethno-pharmacology<br> == | == Ethno-pharmacology<br> == | ||
The Spirit Molecule (Dir. Mitch Schultz, 2010. 10 parts) | The Spirit Molecule (Dir. Mitch Schultz, 2010. 10 parts) | ||
| Line 69: | Line 71: | ||
<youtube>BXNeb60ODG0</youtube> | <youtube>BXNeb60ODG0</youtube> | ||
<br> | <br> | ||
[http://www.frontiersin.org/ethnopharmacology/10.3389/fphar.2010.00008/full Ethnopharmacology in the 21st century – grand challenges ]<br>Michael Heinrich <br> | [http://www.frontiersin.org/ethnopharmacology/10.3389/fphar.2010.00008/full Ethnopharmacology in the 21st century – grand challenges ]<br>Michael Heinrich <br> | ||
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670266/?tool=pubmed Naming a Phantom - the Quest to Find the Identity of the Ulluchu, an Unidentified Cerimonial Plant of the Moche Culture in Northern Peru]<br>Rainer W Bussmann and Douglas Sharon<br> | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670266/?tool=pubmed Naming a Phantom - the Quest to Find the Identity of the Ulluchu, an Unidentified Cerimonial Plant of the Moche Culture in Northern Peru]<br>Rainer W Bussmann and Douglas Sharon<br> | ||
[http://www.substanceabusepolicy.com/content/1/1/14 Absinthism: A Fictitious 19th. Centrury Syndrome with Present Impact]<br>Stephan A Padosch, Dirk W Lachenmeier and Lars U Kröner<br> | [http://www.substanceabusepolicy.com/content/1/1/14 Absinthism: A Fictitious 19th. Centrury Syndrome with Present Impact]<br>Stephan A Padosch, Dirk W Lachenmeier and Lars U Kröner<br> | ||
[http://www.journalofpsychoactivedrugs.com/Articles/Bullis%20402.pdf The “Vine of the Soul” vs. The Controlled Substances Act: Implications of the Hoasca Case]<br>Ronald K. Bullis | [http://www.journalofpsychoactivedrugs.com/Articles/Bullis%20402.pdf The “Vine of the Soul” vs. The Controlled Substances Act: Implications of the Hoasca Case]<br>Ronald K. Bullis | ||
<br> | <br> | ||
== Anthropo-pharmacology == | == Anthropo-pharmacology == | ||
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174878/ The evolutionary origins and significance of drug addiction]<br>Tammy Saah<br><br> | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174878/ The evolutionary origins and significance of drug addiction]<br>Tammy Saah<br><br> | ||
[http://kcl.academia.edu/RichardSullivan/Papers/258342/Why_do_we_love_medicines_so_much Why Do We Love Medicines So Much?] | [http://kcl.academia.edu/RichardSullivan/Papers/258342/Why_do_we_love_medicines_so_much Why Do We Love Medicines So Much?] | ||
| Line 93: | Line 95: | ||
<youtube>dtJ_smUrDaA</youtube> | <youtube>dtJ_smUrDaA</youtube> | ||
<br> | <br> | ||
== Eco-pharmacology == | == Eco-pharmacology == | ||
| Line 99: | Line 101: | ||
[http://www.ehjournal.net/content/pdf/1476-069X-6-20.pdf Pharmacoenvironmentology – a component of pharmacovigilance]<br>Syed Ziaur Rahman, Rahat Ali Khan, Varun Gupta and Misbah Uddin | [http://www.ehjournal.net/content/pdf/1476-069X-6-20.pdf Pharmacoenvironmentology – a component of pharmacovigilance]<br>Syed Ziaur Rahman, Rahat Ali Khan, Varun Gupta and Misbah Uddin | ||
== Juridico-pharmacology<br> == | == Juridico-pharmacology<br> == | ||
Our Right to Drugs | Our Right to Drugs | ||
| Line 107: | Line 109: | ||
Thomas Szasz <youtube>bwBLdGAbDPk</youtube> | Thomas Szasz <youtube>bwBLdGAbDPk</youtube> | ||
<br> | <br> | ||
[http://www.bisdro.uni-bremen.de/boellinger/cannabis/03-zimme.pdf The History of Cannabis Prohibition]<br>Lynn Zimmer | [http://www.bisdro.uni-bremen.de/boellinger/cannabis/03-zimme.pdf The History of Cannabis Prohibition]<br>Lynn Zimmer | ||
<br> | <br> | ||
[http://www.tdpf.org.uk/Transform_After_the_War_on_Drugs.pdf After the War on Drugs: Options for Control] | [http://www.tdpf.org.uk/Transform_After_the_War_on_Drugs.pdf After the War on Drugs: Options for Control] | ||
| Line 117: | Line 119: | ||
A Report by TRANSFORM Drug Policy Foundation | A Report by TRANSFORM Drug Policy Foundation | ||
<br> | <br> | ||
[http://www.demos.co.uk/files/Taking_Drugs_Seriously_-_web.pdf?1305207826 Taking Drugs Seriously: A DEMOS and UK Drug Policy Commission Report on Legal Highs]<br>Jonathan Birdwell, Jake Chapman, Nicola Singleton | [http://www.demos.co.uk/files/Taking_Drugs_Seriously_-_web.pdf?1305207826 Taking Drugs Seriously: A DEMOS and UK Drug Policy Commission Report on Legal Highs]<br>Jonathan Birdwell, Jake Chapman, Nicola Singleton | ||
| Line 129: | Line 131: | ||
[http://www.emcdda.europa.eu/attachements.cfm/att_137215_EN_PolicyProfile_Portugal_WEB_Final.pdf European Monitoring Centre for Drugs and Drug Addiction - Portugal's Drugs Policy] | [http://www.emcdda.europa.eu/attachements.cfm/att_137215_EN_PolicyProfile_Portugal_WEB_Final.pdf European Monitoring Centre for Drugs and Drug Addiction - Portugal's Drugs Policy] | ||
[http://www.globaldrugpolicy.org/5/1/1.php The UK’s Treatment War on Drugs: A Lesson in Unintended Consequences and Perverse Outcomes]<br>Kathy Gyngell<br> | [http://www.globaldrugpolicy.org/5/1/1.php The UK’s Treatment War on Drugs: A Lesson in Unintended Consequences and Perverse Outcomes]<br>Kathy Gyngell<br> | ||
<br> | <br> | ||
== Counter-cultural psycho-pharmacology == | == Counter-cultural psycho-pharmacology == | ||
| Line 139: | Line 141: | ||
Timothy Leary <youtube>msPLOy2q_54</youtube> | Timothy Leary <youtube>msPLOy2q_54</youtube> | ||
<br> | <br> | ||
[http://www.mdma.net/index.html Utopian Pharmacology] | [http://www.mdma.net/index.html Utopian Pharmacology] | ||
| Line 145: | Line 147: | ||
David Pearce | David Pearce | ||
== Aesthetics and anaesthetics<br> == | == Aesthetics and anaesthetics<br> == | ||
[http://rsnr.royalsocietypublishing.org/content/63/3/297.full.pdf+html?sid=eadf5d54-dc6b-4c9d-8719-f9b8aa5ef467 The Atmosphere of Heaven: the 1799 Nitrous Oxide Researches Reconsidered] | [http://rsnr.royalsocietypublishing.org/content/63/3/297.full.pdf+html?sid=eadf5d54-dc6b-4c9d-8719-f9b8aa5ef467 The Atmosphere of Heaven: the 1799 Nitrous Oxide Researches Reconsidered] | ||
| Line 151: | Line 153: | ||
Mike Jay | Mike Jay | ||
<br> | <br> | ||
[http://www.rsc.org/images/Historical%20Profile%20-%20No%20Laughing%20Matter_tcm18-202509.pdf No Laughing Matter] | [http://www.rsc.org/images/Historical%20Profile%20-%20No%20Laughing%20Matter_tcm18-202509.pdf No Laughing Matter] | ||
| Line 163: | Line 165: | ||
Dave Boothroyd | Dave Boothroyd | ||
[http://www.janushead.org/7-1/malins.pdf Machinic Assemblages: Deleuze, Guattari and an Ethico-Aesthetics of Drug Use]<br>Peta Malins<br> | [http://www.janushead.org/7-1/malins.pdf Machinic Assemblages: Deleuze, Guattari and an Ethico-Aesthetics of Drug Use]<br>Peta Malins<br> | ||
<br> | <br> | ||
== Placebo == | == Placebo == | ||
| Line 171: | Line 173: | ||
[http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0020262 Deception in Research on the Placebo Effect] | [http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0020262 Deception in Research on the Placebo Effect] | ||
Franklin G. Miller, David Wendler, Leora C. Swartzman<br> | Franklin G. Miller, David Wendler, Leora C. Swartzman<br> | ||
[http://www.substanceabusepolicy.com/content/2/1/30 Effects of perceived cocaine availability on subjective and objective responses to the drug]<br>Rinah T Yamamoto, Katherine H Karlsgodt, David Rott, Scott E Lukas and Igor Elman | [http://www.substanceabusepolicy.com/content/2/1/30 Effects of perceived cocaine availability on subjective and objective responses to the drug]<br>Rinah T Yamamoto, Katherine H Karlsgodt, David Rott, Scott E Lukas and Igor Elman | ||
<br> | <br> | ||
Understanding the Placebo Effect | Understanding the Placebo Effect | ||
| Line 183: | Line 185: | ||
<youtube>OSx2z4JCWgA</youtube> | <youtube>OSx2z4JCWgA</youtube> | ||
<br> | <br> | ||
== Gonzo-pharmacology == | == Gonzo-pharmacology == | ||
| Line 191: | Line 193: | ||
<youtube>grcqs9cDuN8</youtube> | <youtube>grcqs9cDuN8</youtube> | ||
<br> | <br> | ||
== Heroes of Drugs Research == | == Heroes of Drugs Research == | ||
Revision as of 12:09, 18 July 2011
Introduction
Drugs 'R Us
Dave Boothroyd
Pure pharmacology
Reflections on drug research
James Black
The receptor concept: pharmacology’s big idea
H.P. Rang
The future of pharmacology
Patrick Vallance, Trevor G Smart
How Drugs May Be Tailored to Your Genetic Makeup
Kathy Giacommini
Socio-pharmacology
Epidemiology Meets Cultural Studies: Studying and Understanding Youth Cultures, Clubs and Drugs
Geoffrey Hunt, Molly Moloney, and Kristin Evans
Misuse of "study drugs:" prevalence, consequences, and implications for policy
Steve Sussman, Mary A Pentz, Donna Spruijt-Metz and Toby Miller
Coming to terms with the nonmedical use of prescription medications
Carol J Boyd and Sean E McCabe
A Better Approach to Drugs and Alcohol
Stanton Peele  
Psycho-pharmacology
Psychopharmacology and the Goverment of the Self
David Healy
Do Antidepressants Cure or Create Abnormal Brain States?
Joanna Moncrieff and David Cohen
Neuro-pharmacology
The Dark Side of Ecstasy: Neuropsychiatric Symptoms After Exposure to 3,4-Methylenedioxymetamphetamine
Sunniva Nyberg Karlsen, Olav Spigset, LARS Slørdal
Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs
John H. Halpern, Andrea R. Sherwood, James I. Hudson, Staci Gruber, David Kozin, Harrison G. Pope Jr
Effectiveness of antidepressants: an evidence myth constructed
from a thousand randomized trials?
John PA Ioannidis
Should We Treat Depression with drugs or
psychological interventions? A Reply to Ioannidis
John M Davis, William J Giakas, Jie Qu, Pavan Prasad and Stefan Leucht
The Neural Basis of Drug Addiction
Barry Everitt
Optimized Networks for Time Perception
Martin Wiener, Matthew S. Matell and H B. Coslett
Ethno-pharmacology
The Spirit Molecule (Dir. Mitch Schultz, 2010. 10 parts)
Ethnopharmacology in the 21st century – grand challenges
Michael Heinrich
Naming a Phantom - the Quest to Find the Identity of the Ulluchu, an Unidentified Cerimonial Plant of the Moche Culture in Northern Peru
Rainer W Bussmann and Douglas Sharon
Absinthism: A Fictitious 19th. Centrury Syndrome with Present Impact
Stephan A Padosch, Dirk W Lachenmeier and Lars U Kröner
The “Vine of the Soul” vs. The Controlled Substances Act: Implications of the Hoasca Case
Ronald K. Bullis
Anthropo-pharmacology
The evolutionary origins and significance of drug addiction
Tammy Saah
Why Do We Love Medicines So Much?
Richard Sullivan, Isabel Behncke and Arnie Purushotham
Ibogaine - Rite of Passage (Lun Arts Productions Documentary)
Eco-pharmacology
Pharmacoenvironmentology – a component of pharmacovigilance
Syed Ziaur Rahman, Rahat Ali Khan, Varun Gupta and Misbah Uddin
Juridico-pharmacology
Our Right to Drugs
An interview with Thomas Szasz
Thomas Szasz
The History of Cannabis Prohibition
Lynn Zimmer
After the War on Drugs: Options for Control
A Report by TRANSFORM Drug Policy Foundation
Taking Drugs Seriously: A DEMOS and UK Drug Policy Commission Report on Legal Highs
Jonathan Birdwell, Jake Chapman, Nicola Singleton
Global Commission on Drugs Report (2011)
Drug Policy – Lessons Learnt, and Options for the Future
Mike Trace
European Monitoring Centre for Drugs and Drug Addiction - Portugal's Drugs Policy
The UK’s Treatment War on Drugs: A Lesson in Unintended Consequences and Perverse Outcomes
Kathy Gyngell
Counter-cultural psycho-pharmacology
Timothy Leary, Cooper Union Addess, 1964
Timothy Leary
David Pearce
Aesthetics and anaesthetics
The Atmosphere of Heaven: the 1799 Nitrous Oxide Researches Reconsidered
Mike Jay
John Mann
Narco-cultural theory
Dave Boothroyd
Machinic Assemblages: Deleuze, Guattari and an Ethico-Aesthetics of Drug Use
Peta Malins
Placebo
Deception in Research on the Placebo Effect
Franklin G. Miller, David Wendler, Leora C. Swartzman
Effects of perceived cocaine availability on subjective and objective responses to the drug
Rinah T Yamamoto, Katherine H Karlsgodt, David Rott, Scott E Lukas and Igor Elman
Understanding the Placebo Effect
Roundtable discussion with Robert Ader, Rob DeRubeis, John Kelley, Richard Kradin, and Rosamond Rhodes
Gonzo-pharmacology
Joe Rogan talks about DMT
Heroes of Drugs Research
Alexander Shulgin
Alexander Flemming